Translating digital wrist tomosynthesis as a novel diagnostic aid to enable osteoporosis screening within the widely accessible mammography setting

The Defense Health Agency awarded Henry Ford Health System $3.347 million on September 15, 2026, under the Military Medical Research and Development program (CFDA 12.420) to translate digital wrist tomosynthesis technology as a diagnostic aid for osteoporosis screening within mammography settings. The project runs through September 14, 2030, with work performed in Detroit, Michigan. Digital wrist tomosynthesis represents a novel imaging modality that Henry Ford will adapt and validate for integration into existing mammography workflows to expand osteoporosis screening access. The award funds basic and applied biomedical research intended to transform healthcare delivery and investigate medical solutions relevant to military and civilian populations. Henry Ford Health System is a tax-exempt non-profit healthcare system operating as a research-intensive prime recipient on federal biomedical grants, with substantial prior funding concentration from the National Institutes of Health and emerging engagement with Defense Health Agency and Department of the Army Medical Command on clinical and translational research projects.